Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2000, p. 8035-8046, Vol. 20, No. 21
Research Division, Joslin Diabetes Center,
Harvard Medical School, Boston, Massachusetts 02215
Received 23 March 2000/Returned for modification 8 May
2000/Accepted 9 August 2000
Phosphoinositide (PI) 3-kinase is a key mediator of
insulin-dependent metabolic actions, including stimulation of glucose transport and glycogen synthesis. The gene for the p85
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Positive and Negative Regulation of
Phosphoinositide 3-Kinase-Dependent Signaling Pathways by Three
Different Gene Products of the p85
Regulatory Subunit
regulatory subunit yields three splicing variants, p85
, AS53/p55
, and
p50
. All three have (i) a C-terminal structure consisting of two Src homology 2 domains flanking the p110 catalytic subunit-binding domain
and (ii) a unique N-terminal region of 304, 34, and 6 amino acids,
respectively. To determine if these regulatory subunits differ in their
effects on enzyme activity and signal transduction from insulin
receptor substrate (IRS) proteins under physiological conditions, we
expressed each regulatory subunit in fully differentiated L6 myotubes
using adenovirus-mediated gene transfer with or without coexpression of
the p110
catalytic subunit. PI 3-kinase activity associated with
p50
was greater than that associated with p85
or AS53. Increasing
the level of p85
or AS53, but not p50
, inhibited both
phosphotyrosine-associated and p110-associated PI 3-kinase activities.
Expression of a p85
mutant lacking the p110-binding site (
p85)
also inhibited phosphotyrosine-associated PI 3-kinase activity but not
p110-associated activity. Insulin stimulation of two kinases downstream
from PI-3 kinase, Akt and p70 S6 kinase (p70S6K), was
decreased in cells expressing p85
or AS53 but not in cells expressing p50
. Similar inhibition of PI 3-kinase, Akt, and
p70S6K was observed, even when p110
was coexpressed with
p85
or AS53. Expression of p110
alone dramatically increased
glucose transport but decreased glycogen synthase activity. This effect
was reduced when p110
was coexpressed with any of the three
regulatory subunits. Thus, the three different isoforms of regulatory
subunit can relay the signal from IRS proteins to the p110 catalytic
subunit with different efficiencies. They also negatively modulate the
PI 3-kinase catalytic activity but to different extents, dependent on
the unique N-terminal structure of each isoform. These data also
suggest the existence of a mechanism by which regulatory subunits
modulate the PI 3-kinase-mediated signals, independent of the kinase
activity, possibly through subcellular localization of the catalytic
subunit or interaction with additional signaling molecules.
*
Corresponding author. Mailing address: Joslin Diabetes
Center, One Joslin Place, Boston, MA 02215. Phone: (617) 732-2635. Fax:
(617) 732-2593. E-mail:
c.ronald.kahn{at}joslin.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|